| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |